Literature DB >> 21400548

Apical hypertrophic cardiomyopathy: correlations between echocardiographic parameters, angiographic left ventricular morphology, and clinical outcomes.

Chao-Chin Chen1, Meng-Huan Lei, Yu-Cheng Hsu, Sheng-Liang Chung, Yen-Jen Sung.   

Abstract

BACKGROUND: Echocardiographic parameters could be implicated in the development of apical asynergy (characterized by apical sequestration or apical aneurysm) and worse cardiovascular outcome in patients with apical hypertrophic cardiomyopathy (ApHCM). HYPOTHESIS: Echocardiographic parameters and morphological patterns of left ventriculograms are associated with cardiovascular morbidity and mortality in patients with ApHCM.
METHODS: We followed 47 cases with echocardiographically documented ApHCM. Echocardiographic findings of the extent and degree of hypertrophy, sustained cavity obliteration, and paradoxical diastolic jet flow were measured. All patients underwent a cardiac catheterization except for the cases whose informed consent was not acquired. The clinical manifestations were assessed and recorded by the attending physicians during 35.4 ± 23.7 months follow-up.
RESULTS: Among the 47 patients with ApHCM, 30 patients presented as the "pure" form and 17 patients present as the "mixed" form. Seventeen of 28 patients with sustained cavity obliteration showed paradoxical flow by echocardiography. Thirty-one underwent left ventriculograms and showed morphological abnormalities, including "ace-of-spades" configuration (15/31), apical sequestration (12/31), and apical aneurysm (4/31). The results demonstrated that cardiovascular morbidities occurred in 21 of 47 patients and were closely related to the presence of mixed form ApHCM, cavity obliteration, and paradoxical flow by univariate and multivariate Cox analysis. During the period of follow-up, 4 patients (9.5%) died, and among them 3 had concomitant apical aneurysm.
CONCLUSIONS: We concluded that detection of cavity obliteration and paradoxical flow and discrimination of pure form from mixed form by echocardiography, as well apical sequestration from apical aneurysm in ApHCM patients, is warranted.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21400548      PMCID: PMC6652360          DOI: 10.1002/clc.20874

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

1.  Apical hypertrophic cardiomyopathy.

Authors:  Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2012

2.  Association of ST elevation with apical aneurysm in hypertrophic cardiomyopathy.

Authors:  Ozcan Ozeke; Cagatay Ertan; Gokhan Keskin; Bulent Deveci; Serkan Cay; Fırat Ozcan; Serkan Topaloglu; Dursun Aras; Ahmet Duran Demir; Sinan Aydogdu
Journal:  Indian Heart J       Date:  2015-08-08

3.  Apical Hypertrophic Cardiomyopathy: The Ace-of-Spades as the Disease Card.

Authors:  Camelia C Diaconu; Nicoleta Dumitru; Ana G Fruntelata; Smarandita Lacau; Daniela Bartos
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

4.  Sudden cardiac arrest in hypertrophic cardiomyopathy with dynamic cavity obstruction: The case for a decatecholaminisation strategy.

Authors:  Cosmin Balan; Adrian View-Kim Wong
Journal:  J Intensive Care Soc       Date:  2017-10-09

5.  Apical Hypertrophic Cardiomyopathy: The Variant Less Known.

Authors:  Rebecca K Hughes; Kristopher D Knott; James Malcolmson; João B Augusto; Saidi A Mohiddin; Peter Kellman; James C Moon; Gabriella Captur
Journal:  J Am Heart Assoc       Date:  2020-02-28       Impact factor: 5.501

6.  Late onset apical hypertrophic cardiomyopathy: a case report.

Authors:  Patrick Doeblin; Rolf Gebker; Burkert Pieske; Sebastian Kelle
Journal:  Eur Heart J Case Rep       Date:  2020-12-12

7.  Yamaguchi Syndrome: A Hidden Masquerader of Ischemic Heart Disease.

Authors:  Anamika Giri; Sourya Acharya; Sandeep Kamat; Samarth Shukla; Sunil Kumar
Journal:  Cureus       Date:  2022-06-29

8.  Mechanical aberrations in hypetrophic cardiomyopathy: emerging concepts.

Authors:  Dimitrios Ntelios; Georgios Tzimagiorgis; Georgios K Efthimiadis; Haralambos Karvounis
Journal:  Front Physiol       Date:  2015-08-19       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.